ProKidney
PROK
65 hedge funds and large institutions have $98.8M invested in ProKidney in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 7 closing their positions.
290% more call options, than puts
Call options by funds: $1.18M | Put options by funds: $303K
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
124% more capital invested
Capital invested by funds: $44.1M → $98.8M (+$54.7M)
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
18% more funds holding
Funds holding: 55 → 65 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.9% less ownership
Funds ownership: 40.01% → 34.12% (-5.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$14.7M |
| 2 |
Morgan Stanley
New York
|
+$11.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.8M |
| 4 |
BlackRock
New York
|
+$2.48M |
| 5 |
BL
Bleichroeder LP
New York
|
+$1.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.22M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$633K |
| 3 |
HF
HRT Financial
New York
|
-$281K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$242K |
| 5 |
Amundi
Paris,
France
|
-$209K |
PROK Hedge Fund Activity: Q2 2024 in Review
65 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2024, worth a combined $98.8M — up 124% from $44.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PROK positions and 7 closed out — a net gain of 10 holders — while 27 added to existing stakes and 13 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $14.7M. The largest seller was Millennium Management, cutting an estimated $1.22M.
- 65 institutional investors held ProKidney (PROK) as of Q2 2024, up from 55 in Q1 2024.
- Funds reported $98.8M of ProKidney stock for Q2 2024, up 124% quarter-over-quarter.
- 17 funds opened new ProKidney positions in Q2 2024 and 7 closed out, a net change of +10 holders.
- The largest ProKidney buyer in Q2 2024 was Suvretta Capital Management, an estimated $14.7M added.
- The largest ProKidney seller in Q2 2024 was Millennium Management, an estimated $1.22M sold.
Based on aggregated 13F filings for Q2 2024.